CDH1 gene promoter hypermethylation in gastric cancer: Relationship to Goseki grading, microsatellite instability status, and EBV invasion

Diagnostic Molecular Pathology

Volumn 15, Issue 1, 2006, Pages 24-29

  Zazula, Monika ^a   Ferreira, Ana Maria ^b   Czopek, Jacek P ^a   Kolodziejczyk, Piotr ^a   Sinczak Kuta, Anna ^a   Klimkowska, Agnieszka ^a   Wojcik, Piotr ^a   Okon, Krzysztof ^a   Bialas, Magdalena ^a   Kulig, Jan ^a   Stachura, Jerzy ^a,c  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b UNIVERSITY OF PORTO   (Portugal)

^c JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

CDH1 promoter hypermethylation; E cadherin; Gastric cancer; Goseki grading

Indexed keywords

UVOMORULIN;

ARTICLE; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; EPSTEIN BARR VIRUS; EXON; FEMALE; GENDER AND SEX; GENE FREQUENCY; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY LOSS; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; METHYLATION; MICROSATELLITE INSTABILITY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH CANCER; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; DNA METHYLATION; FEMALE; GENOMIC INSTABILITY; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM STAGING; PROMOTER REGIONS (GENETICS); STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 33645675495     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-200603000-00004     Document Type: Article

References (33)

1. Takeichi M. Cadherin cell adhesion receptors as a morphogenic regulator. Science. 1991;251:1454-1455.
2. Huber O, Bierkamp C, Kemler R. Cadherins and catenins in development. Curr Opin Cell Biol. 1996;8:685-691.
3. Berx G, Becker KF, Hofler H, et al. Mutations of the human E-cadherin (CDH1) gene. Hum Mutat. 1998;12:226-237.
4. Stone J, Bevan S, Cunningham D, et al. Low frequency of germline E-cadherin mutations in familial and nonfamilial gastric cancer. Br J Cancer. 1999;79:1935-1937.
5. Yoshiura K, Kanai Y, Ochiai A, et al. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcino-mas. Proc Natl Acad Sci USA. 1995;92:7416-7419.
6. Wijnhoven BP, Dinjens WN, Pignatelli M. E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg. 2000;87: 992-1005.
7. Baylin SB, Belinsky SA, Herman JG. Aberrant methylation of gene promoters in cancer. Concepts, misconcepts and promise. J Natl Cancer Inst. 2000;92:1460-1461.
8. Grady WM, Willis J, Guilford PJ, et al. Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet. 2000;26:16-17.
9. Machado JC, Oliveira C, Carvalho R, et al. E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma. Oncogene. 2001;20:1525-1528.
10. Kang GH, Lee HJ, Hwang KS, et al. Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol. 2003;163:1551-1556.
11. Kim H, Kim YH, Kim SE, et al. Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability. J Pathol. 2003;200:23-31.
12. Suzuki H, Itoh F, Toyota M, et al. Distinct methylation pattern and microsatellite instability in sporadic gastric cancer. Int J Cancer. 1999;83:309-313.
13. Issa JP, Ahuja N, Toyota M, et al. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 2001;61: 3573-3577.
14. Sudo M, Chong JM, Sakuma K, et al. Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer. 2004;109:194-199.
15. Ahuja N, Li Q, Mohan AL, et al. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res. 1998;58:5489-5494.
16. Hamilton SR, Aaltonen LA. World Health Organization Classification of Tumours (vol 2). Pathology and Genetics of Tumours of the Digestive System. Lyon, France: IARC Press; 2000.
17. Goseki N, Takizawa T, Koike M. Differences in the mode of the extension of gastric cancer classified by histological type: new histological classification of gastric carcinoma. Gut. 1992;33:606-612.
18. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand. 1965;64:31-49.
19. Oliveira C, Bordin MC, Grehan N, et al. Screening E-cadherin in gastric cancer families reveals germline mutations only in hereditary diffuse gastric cancer kindred. Hum Mutat. 2002;19:510-517.
20. Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 1996;93:9821-9826.
21. Czopek JP, Bialas M, Rudzki Z, et al. The relationship between gastric cancer cells circulating in the blood and microsatellite instability positive gastric carcinomas. Aliment Pharmacol Ther. 2002;16:128-136.
22. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998;58:5248-5257.
23. Graziano F, Humar B, Guilford P. The role of the E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice. Ann Oncol. 2003;14:1705-1713.
24. Tamura G, Yin J, Wang S, et al. E-cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst. 2000;92:569-573.
25. Carvalho B, Pinto M, Cirnes L, et al. Concurrent hypermethylation of gene promoters is associated with a MSI-H phenotype and diploidy in gastric carcinomas. Eur J Cancer. 2003;39:1222-1227.
26. Lee TL, Leung WK, Chan MW, et al. Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. Clin Cancer Res. 2002;8:1761-1766.
27. Fontana MG, La Pinta M, Moneghini D, et al. Prognostic value of Goseki histological classification in adenocarcinoma of the cardia. Br J Cancer. 2003;88:401-405.
28. House MG, Herman JG, Guo MZ, et al. Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms. Ann Surg. 2003;238:423-431.
29. Hasegawa M, Nelson HH, Peters E, et al. Patterns of gene promoter methylation in squamous cell cancer of the head and neck. Oncogene. 2002;21:4231-4236.
30. Calvisi DF, Ladu S, Conner EA, et al. Disregulation of E-cadherin in transgenic mouse models of liver cancer. Lab Invest. 2004;84:1137-1147.
31. Yuasa Y. DNA methylation in cancer and ageing. Mech Ageing Dev. 2002;123:1649-1654.
32. Chong JM, Sakuma K, Sudo M, et al. Global and Non-random CpG island methylation in gastric carcinoma associated with Epstein-Barr virus. Cancer Sci. 2003;94:76-80.
33. Chang MS, Lee HS, Kim HS, et al. Epstein-Barr virus and microsatellite instability in gastric carcinogenesis. J Pathol. 2003;199:447-452.